DigestRedComo funciona
Red
/
Empresas
Ha
No verificado

Harmony Biosciences Holdings, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludWeb y redes sociales

26 Comunicados de prensa

Ver todos los comunicados de prensa
12/01/2026
Salud
Medicina - Varios
Sanidad
Farmacéutica
Biotecnología
Industria
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
07/01/2026
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Web y redes sociales
Eventos
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
08/12/2025
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
02/12/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
24/11/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Industria
Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
19/11/2025
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist (BP1.15205) for Central Disorders of Hypersomnolence
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
04/11/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Web y redes sociales
Telefonía
Mercado de valores
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
23/10/2025
Venta al público/Minorista
Industria
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
24/09/2025
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0
26/08/2025
Ciencia
Biotecnología
Sanidad
Salud
Farmacéutica
Eventos
Industria
Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
Fuente
Harmony Biosciences Holdings, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0